FDA Approves CLARAVIS — Teva Pharmaceuticals USA, Inc.

TEVA PHARMACEUTICALS USA, INC. received FDA approval on April 11, 2003 for Claravis, a generic version of the acne-treating drug isotretinoin, entitling the company to an initial 180-day period of generic exclusivity. This specific authorization did not alter the current competitive landscape, as Claravis is already widely available from other manufacturers.